How can we, humans, look at our relationship to nature differently? In season three of Going Wild, on top of stories about animals, we invite you to journey through the entire ecological web — from the tiniest of life forms to apex predators — alongside the scientists, activists and adventurers who study it. Wildlife biologist and host Dr. Rae Wynn-Grant has been studying wild animals in their natural habitats all over the world for years. Our award-winning podcast takes you inside the hidde ...
…
continue reading
Content provided by Sano Genetics. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Sano Genetics or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!
Go offline with the Player FM app!
EP 128: Parkinson’s disease and precision medicine with Drs. James Beck and Ignacio Mata
MP3•Episode home
Manage episode 409217219 series 2631947
Content provided by Sano Genetics. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Sano Genetics or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
0:00 Introduction
1:05 Insights into the PD GENEration’s (a programme from the Parkinson's Foundation) milestones and progress points for the upcoming year
3:30 The shifting attitudes and perspectives of neurologists and healthcare workers at the PD GENEration
5:50 Insights into Nacho’s work with the genetics of Parkinson’s disease
10:20 Barriers and facilitators to increasing Latino representation in Parkinson’s disease research, including the return of results process in Latin America
17:30 The PD GENEration’s efforts to increase the participation of ethnic minority groups in genetic studies and research
24:15 How to effectively choose inclusive and accessible clinical sites in Latin America
30:10 Major genes implicated in Parkinson’s disease and the potential for prediction and prevention via screening programmes
36:30 The implications of environmental and genetic risk factors for family members of those living with PD
45:00 Promising programmes in PD research and clinical trials, such as Denali and Biogen’s joint effort to develop small molecule inhibitors of LRRK2
48:40 Best practices for community and patient engagement to speed up the process for clinical trials
54:30 Closing remarks
Please consider rating and reviewing us on your chosen podcast listening platform!
177 episodes
MP3•Episode home
Manage episode 409217219 series 2631947
Content provided by Sano Genetics. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Sano Genetics or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
0:00 Introduction
1:05 Insights into the PD GENEration’s (a programme from the Parkinson's Foundation) milestones and progress points for the upcoming year
3:30 The shifting attitudes and perspectives of neurologists and healthcare workers at the PD GENEration
5:50 Insights into Nacho’s work with the genetics of Parkinson’s disease
10:20 Barriers and facilitators to increasing Latino representation in Parkinson’s disease research, including the return of results process in Latin America
17:30 The PD GENEration’s efforts to increase the participation of ethnic minority groups in genetic studies and research
24:15 How to effectively choose inclusive and accessible clinical sites in Latin America
30:10 Major genes implicated in Parkinson’s disease and the potential for prediction and prevention via screening programmes
36:30 The implications of environmental and genetic risk factors for family members of those living with PD
45:00 Promising programmes in PD research and clinical trials, such as Denali and Biogen’s joint effort to develop small molecule inhibitors of LRRK2
48:40 Best practices for community and patient engagement to speed up the process for clinical trials
54:30 Closing remarks
Please consider rating and reviewing us on your chosen podcast listening platform!
177 episodes
Kaikki jaksot
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.